Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
25I-NBF emerged as part of the broader NBOMe and NBF series of N-benzyl phenethylamine derivatives developed for research purposes. The compound has been investigated in its carbon-11 radiolabelled form (designated Cimbi-21) as a potential ligand for positron emission tomography (PET) imaging,…
Classified as a prohibited substance under national drug legislation.
Prohibited under national controlled substances legislation.
Controlled under the Misuse of Drugs Act 1971 via the N-benzylphenethylamine catch-all clause. Class A substances carry the most severe penalties, including up to 7 years imprisonment for possession.
Controlled as a designated substance under Japanese drug control laws.
Added to the Narcotic Drugs Punishments Act on January 26, 2016. Listed under Swedish Schedule I as a substance without accepted medical use, published by the Medical Products Agency in regulation HSLF-FS 2015:35.
Not federally scheduled at the national level. The state of Vermont has independently classified 25I-NBF as an illegal substance. Federal prosecution may still be possible under the Federal Analogue Act when sold for human consumption.
6 sources cited